🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

GAiT speaking at #VLGeneCell conference 9th June 2022 in Berlin

GAiT will speak at the iPSC Manufacturing Summit in Boston 26th-28th July 2022 ipsc-manufacturing-summit.com

ipsc-manufacturing-summit.com

GAiT Directors Jihwan Song and Anna Falk and @NYSCF Representative Jeff Wallerstein discuss a global haplobank network for clinical-grade iPS cells at #ISSCR2022

GAiT will speak at the iPSC Manufacturing Summit in Boston next week. Details at ipsc-manufacturing-summit.com

iPSC Quality Round Participants have received automated emails regarding manuscript submission this week. We would be grateful if you can respond to these. If you have already done so, thank you.

GAiT is happy to chair this morning's session entitled "Equipping iPSC Expansion Practices to Cater for Scale-Up & Commercialization" at the iPSC Manufacturing Summit ipsc-manufacturing-summit.com

At day 2 of the iPSC Manufacturing Summit, GAiT is chairing this morning's session entitled "Developing iPSC Differentiation to Efficently Create the Desired Cell Type". ipsc-manufacturing-summit.com

We want safe and efficacious iPSC therapeutics that have clinical impact globally. Is Quality Testing consistent and indicative for your "clinical-grade" iPSCs? GAiT & 公益財団法人 京都大学iPS細胞研究財団 conduct iPSC Quality Assessment Rounds to assist efficient translation.

What is a target product profile (TPP) and why should you have one for you CAR T-cell therapy? A guest blogger from CCRM_au explains. signalsblog.ca/target-product…

GAiT and CiRA Foundation are grateful for all those organizations who will participate in the 2nd iPSC Quality Assessment Round. We should be in touch with you shortly with extra information.

NYSCF's annual scientific meeting in New York 18-19th October 2022. Speakers list and registration can be accessed at conference.nyscf.org/program/

Characterization of advanced therapies: leveraging advanced #analytics to avoid #FDA holds Find out the key #assay types needed for successful characterization of #cellandgenetherapy Read the FastFacts poster, or watch the video, here: bit.ly/3AxQmMz #celltherapy

GAiT looks forward to speaking to Indian Colleagues from CMC Vellore at the 7th Cell and Gene Therapy Symposium 1st -3rd September 2022. cscr.res.in/symposium

advancedtherapiesweek.phacilitate.com

Companies developing iPSC-based cell therapies

Great panel on regulatory futures for CGT from various perspectives - Niloofar Davoodi, Takeda, Ian Rees, MHRAgovuk, Michael von Forstner, Biogen and led by Jacqueline Barry, Cell and Gene Therapy Catapult #advancedtherapieseurope #ate2022 #ate22 #celltherapy #regulatory

With a very heavy heart, we announce the passing of our CEO and co-founder, Susan Solomon, following a long battle with ovarian cancer. We owe all that NYSCF has accomplished to Susan, and no words can express our gratitude and awe for her catalytic impact on stem cell research.

GAiT joins CCRM on their latest podcast to discuss the clinical potential of induced Pluripotent Stem Cells podcasts.apple.com/us/podcast/unl…

We hope you will cheer on Michael May CCRM when he receives the 2023 Le Prix Luc Sensebé Innovation and Leadership Award at ISCT's welcome address and major awards presentation on May 31 in Paris. Congratulations to all the award recipients: isctglobal.org/isct2023/progr…